SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021186
Filing Date
2023-05-11
Accepted
2023-05-11 16:02:01
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q elym-20230331.htm   iXBRL 10-Q 2450348
2 EX-31.1 elym-ex31_1.htm EX-31.1 21320
3 EX-32.1 elym-ex32_1.htm EX-32.1 12885
  Complete submission text file 0000950170-23-021186.txt   8635427

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elym-20230331_def.xml EX-101.DEF 152931
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elym-20230331.xsd EX-101.SCH 56240
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elym-20230331_cal.xml EX-101.CAL 36860
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elym-20230331_lab.xml EX-101.LAB 426329
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elym-20230331_pre.xml EX-101.PRE 318844
53 EXTRACTED XBRL INSTANCE DOCUMENT elym-20230331_htm.xml XML 1788858
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40708 | Film No.: 23910797
SIC: 2834 Pharmaceutical Preparations